NeuroMetrix launches chronic pain relief device at CES

 

 

WALTHAM, Mass.— NeuroMetrix is making a splash at this year's International Consumer Electronics Show with its launch of Quell, an OTC chronic pain relieving device. 

 

Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technology to provide relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia and degenerative knee conditions. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the Food and Drug Administration for treatment of chronic pain without a prescription. Users of the device also will have the option of using their smartphone to automatically track and personalize their pain therapy.

 

The company expects to begin taking pre-orders for Quell in March and to ship during the second quarter. Quell will initially be available exclusively through doctor’s offices and online.